National Health Investors, Inc.

Symbol: NHI

NYSE

65.45

USD

Market price today

  • 21.4996

    P/E Ratio

  • 0.5485

    PEG Ratio

  • 2.84B

    MRK Cap

  • 0.06%

    DIV Yield

National Health Investors, Inc. (NHI) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.96%

Operating Profit Margin

0.48%

Net Profit Margin

0.43%

Return on Assets

0.05%

Return on Equity

0.11%

Return on Capital Employed

0.06%

Company general description and statistics

Sector: Real Estate
Industry: REIT - Healthcare Facilities
CEO:Mr. D. Eric Mendelsohn
Full-time employees:26
City:Murfreesboro
Address:222 Robert Rose Drive
IPO:1991-10-09
CIK:0000877860

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

General Outlook

When we look at how much money they make before expenses, they keep 0.962% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.478%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.432%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.053% return, is a testament to National Health Investors, Inc.'s adeptness in optimizing resource deployment. National Health Investors, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.105%. Furthermore, the proficiency of National Health Investors, Inc. in capital utilization is underscored by a remarkable 0.059% return on capital employed.

Stock Prices

National Health Investors, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $64.42, while its low point bottomed out at $63.14. This variance in figures offers investors a lucid insight into the roller-coaster ride that is National Health Investors, Inc.'s stock market.

Liquidity Ratios

Analyzing NHI liquidity ratios reveals its financial health of the firm. The current ratio of 6529.53% gauges short-term asset coverage for liabilities. The quick ratio (6529.53%) assesses immediate liquidity, while the cash ratio (209.19%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio6529.53%
Quick Ratio6529.53%
Cash Ratio209.19%

Profitability Ratios

NHI profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 42.91% underscores its earnings before tax deductions. The effective tax rate stands at 31.67%, revealing its tax efficiency. The net income per EBT, 100.68%, and the EBT per EBIT, 89.73%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 47.82%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin42.91%
Effective Tax Rate31.67%
Net Income per EBT100.68%
EBT per EBIT89.73%
EBIT per Revenue47.82%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 65.30, it details the span from stock purchase to revenue. The 65 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 89.09% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding6530
Operating Cycle409.69
Cash Conversion Cycle410
Receivables Turnover0.89
Asset Turnover0.12

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 4.48, and free cash flow per share, 4.37, depict cash generation on a per-share basis. The cash per share value, 0.26, showcases liquidity position. A payout ratio of 1.18 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.64, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share4.48
Free Cash Flow per Share4.37
Cash per Share0.26
Payout Ratio1.18
Operating Cash Flow Sales Ratio0.64
Free Cash Flow to Operating Cash Flow Ratio0.98
Capital Expenditure Coverage Ratio43.10
Dividend Paid and Capex Coverage Ratio1.21
Dividend Payout Ratio0.06

Debt and Leverage Ratios

An interest coverage of 3.47 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage3.47
Company Equity Multiplier1.99

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 7.37, provides a glimpse into top-line earnings distributed across each share. Net income per share, 3.13, reflects the portion of profit attributed to each share. The book value per share, 28.90, represents the net asset value distributed per share, while the tangible book value per share, 29.36, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share7.37
Net Income Per Share3.13
Book Value Per Share28.90
Tangible Book Value Per Share29.36
Shareholders Equity Per Share28.90
Interest Debt Per Share29.18
Capex Per Share-0.09

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 14.97%, indicates top-line expansion, while the gross profit growth, 14.87%, reveals profitability trends. EBIT growth, -99.98%, and operating income growth, -99.98%, offer insights into operational profitability progression. The net income growth, 488.27%, showcases bottom-line expansion, and the EPS growth, 501.92%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth14.97%
Gross Profit Growth14.87%
EBIT Growth-99.98%
Operating Income Growth-99.98%
Net Income Growth488.27%
EPS Growth501.92%
EPS Diluted Growth513.73%
Weighted Average Shares Growth-3.10%
Weighted Average Shares Diluted Growth-3.14%
Dividends per Share Growth-0.34%
Operating Cash Flow Growth-0.48%
10-Year Revenue Growth per Share77.44%
5-Year Revenue Growth per Share4.95%
3-Year Revenue Growth per Share-1.00%
10-Year Operating CF Growth per Share15.72%
5-Year Operating CF Growth per Share-14.22%
3-Year Operating CF Growth per Share-18.15%
10-Year Net Income Growth per Share-16.49%
5-Year Net Income Growth per Share-15.03%
3-Year Net Income Growth per Share3.23%
10-Year Shareholders Equity Growth per Share6.93%
5-Year Shareholders Equity Growth per Share-12.77%
3-Year Shareholders Equity Growth per Share-14.58%
10-Year Dividend per Share Growth per Share19.95%
5-Year Dividend per Share Growth per Share-8.68%
3-Year Dividend per Share Growth per Share-17.29%
Receivables Growth6.32%
Asset Growth-0.76%
Book Value per Share Growth1.87%
Debt Growth-1.09%
SGA Expenses Growth-21.73%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,535,968,144.9, captures the company's total value, considering both debt and equity. Income quality, 1.37, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value3,535,968,144.9
Income Quality1.37
Sales General and Administrative to Revenue0.06
Capex to Operating Cash Flow-2.03%
Capex to Revenue-1.17%
Capex to Depreciation-5.35%
Stock-Based Compensation to Revenue1.44%
Graham Number45.09
Return on Tangible Assets5.45%
Graham Net Net-17.54
Working Capital285,139,000
Tangible Asset Value1,274,047,000
Net Current Asset Value-849,912,000
Invested Capital1
Average Receivables324,949,000
Average Payables30,104,500
Average Inventory179,802,500
Days Sales Outstanding382
Days Payables Outstanding1088
Days of Inventory On Hand11401
ROE0.11%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.28, and the price to book ratio, 2.28, reflect the market's valuation relative to the company's book value. The price to sales ratio, 9.30, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 14.98, and price to operating cash flows, 14.62, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.28
Price to Book Ratio2.28
Price to Sales Ratio9.30
Price Cash Flow Ratio14.62
Price Earnings to Growth Ratio0.55
Enterprise Value Multiple11.84
Price Fair Value2.28
Price to Operating Cash Flow Ratio14.62
Price to Free Cash Flows Ratio14.98
Price to Tangible Book Ratio1.93
Enterprise Value to Sales11.06
Enterprise Value Over EBITDA14.32
EV to Operating Cash Flow19.17
Earnings Yield5.60%
Free Cash Flow Yield7.46%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of National Health Investors, Inc. (NHI) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 21.500 in 2024.

What is the ticker symbol of National Health Investors, Inc. stock?

The ticker symbol of National Health Investors, Inc. stock is NHI.

What is company IPO date?

IPO date of National Health Investors, Inc. is 1991-10-09.

What is company current share price?

Current share price is 65.450 USD.

What is stock market cap today?

The market cap of stock today is 2842153160.000.

What is PEG ratio in 2024?

The current 0.548 is 0.548 in 2024.

What is the number of employees in 2024?

In 2024 the company has 26.